0001004878-17-000117.txt : 20170512 0001004878-17-000117.hdr.sgml : 20170512 20170512172217 ACCESSION NUMBER: 0001004878-17-000117 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170512 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170512 DATE AS OF CHANGE: 20170512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 17839995 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 8-K 1 form8kitem801may-17.txt FORM 8-K ITEM 8.01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 12, 2017 CEL-SCI CORPORATION ------------------------------------- (Exact name of Registrant as specified in its charter) Colorado 001-11889 84-0916344 -------------------- ------------------ ----------------- (State or other jurisdiction (Commission File No.) (IRS Employer of incorporation) Identification No.) 8229 Boone Boulevard, Suite 802 Vienna, Virginia 22182 ------------------------------------- (Address of principal executive offices, including Zip Code) Registrant's telephone number, including area code: (703) 506-9460 N/A ------------------------------ (Former name or former address if changed since last report) Item 8.01 Other Events On May 12, 2017 the Company issued a press release, filed as Exhibit 99, regarding the rescheduling of its annual meeting of shareholders to June 12, 2017. Item 9.01 Exhibits Exhibit Number Description of Document ------ ----------------------- 99 May 12, 2017 Press Release. 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 12, 2017 CEL-SCI CORPORATION By: /s/ Patricia B. Prichep -------------------------------------- Patricia B. Prichep Senior Vice President of Operations EX-99 2 form8kitem801ex99may-17.txt EXHIBIT 99 PRTESS RELEASE EXHIBIT 99 8229 Boone Boulevard, Suite 802 COMPANY CONTACT: Vienna, VA 22182. USA Gavin de Windt Telephone (703) 506-9460 CEL-SCI Corporation www.cel-sci.com (703) 506-9460 CEL-SCI ANNOUNCES CHANGE TO THE DATE OF ITS ANNUAL MEETING Vienna, VA, Friday, May 12, 2017 - CEL-SCI Corporation (NYSE MKT: CVM) today announced it has changed the date for its annual meeting from June 9, 2017 to June 12, 2017. The Company's annual meeting is now scheduled for Monday, June 12, 2017 at 10:30 a.m. local time. The meeting will be held at 4820-C Seton Drive, Baltimore, MD 21215. No changes have been made to the record date or the proposals to be brought before the annual meeting, which are presented in the Proxy Statement that the Company filed with the Securities and Exchange Commission (SEC) on April 27, 2017. Stockholders who have already submitted a proxy or voting instructions do not need to take any further action. The Company's Proxy Statement and Annual Report filed by the Company with the SEC are available on the SEC's website at http://www.sec.gov. About CEL-SCI Corporation CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. The Company has operations in Vienna, Virginia, and in/near Baltimore, Maryland.